Skip to content
HowShorted

How shorted is Sunshine Biopharma Inc.? SBFM

2.24%
of shares outstanding reported short · settlement date 31 Aug 2026
vs previous report
+0.33
5 reports (~10 weeks)
−0.50
days to cover
1.00
Aggregate net short position time series for Sunshine Biopharma Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Sunshine Biopharma Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
9 Apr 20262.85% 31 Mar 20262.74% 15 Apr 2026−0.11
19 May 20259.57% 15 May 20255.68% 30 May 2025−3.89
2 Apr 20255.22% 31 Mar 20254.51% 15 Apr 2025−0.71
13 Nov 20230.52% 31 Oct 20230.37% 15 Nov 2023−0.15
11 Aug 20230.33% 31 Jul 20232.30% 15 Aug 2023+1.97
11 May 20231.17% 28 Apr 20232.39% 31 May 2023+1.22

Fails to deliver

The SEC's fails-to-deliver figure for SBFM: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
5,546
1 Sep 2026
Highest in window
383,961
3 Jun 2026
Days with a balance
116
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Sunshine Biopharma Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 384K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Share on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2022 · 2023 · 2024 · 2025 · 2026

History

Full reported short interest history
Settlement dateShort %Change
31 Aug 20262.24%+0.33
14 Aug 20261.91%−0.67
31 Jul 20262.58%+1.31
15 Jul 20261.27%−0.85
30 Apr 20262.12%−0.62
15 Apr 20262.74%−0.11
31 Mar 20262.85%−0.54
13 Mar 20263.39%−1.21
27 Feb 20264.60%−0.19
13 Feb 20264.79%−0.94
30 Jan 20265.73%−0.53
15 Jan 20266.26%−0.55
31 Dec 20256.81%−1.21
15 Dec 20258.02%−0.75
28 Nov 20258.77%−3.25
14 Nov 202512.02%+4.01
15 Oct 20258.01%+3.43
30 Sep 20254.58%−0.22
15 Sep 20254.80%−0.64
29 Aug 20255.44%−0.89
15 Aug 20256.33%+3.02
30 Jun 20253.31%−0.20
13 Jun 20253.51%−2.17
30 May 20255.68%−3.89
15 May 20259.57%+5.06
15 Apr 20254.51%−0.71
31 Mar 20255.22%−0.44
14 Mar 20255.66%−5.24
31 Dec 202410.90%−12.82
13 Dec 202423.72%−4.07
29 Nov 202427.79%+16.09
15 Nov 202411.70%+9.21
31 Jul 20242.49%+0.59
15 Jul 20241.90%+1.07
31 May 20240.83%+0.43
31 Jan 20240.40%−0.04
12 Jan 20240.44%−0.01
29 Dec 20230.45%+0.22
15 Dec 20230.23%−0.06
30 Nov 20230.29%−0.08
15 Nov 20230.37%−0.15
31 Oct 20230.52%−0.29
13 Oct 20230.81%+0.07
29 Sep 20230.74%+0.02
15 Sep 20230.72%−0.37
31 Aug 20231.09%−1.21
15 Aug 20232.30%+1.97
31 Jul 20230.33%−0.36
14 Jul 20230.69%−0.33
30 Jun 20231.02%−0.41
15 Jun 20231.43%−0.96
31 May 20232.39%+1.22
28 Apr 20231.17%−0.08
14 Apr 20231.25%+0.27
31 Mar 20230.98%−0.37
15 Mar 20231.35%−0.22
28 Feb 20231.57%−0.32
15 Feb 20231.89%+0.14
31 Jan 20231.75%+0.39
13 Jan 20231.36%−0.33
30 Dec 20221.69%−0.30
15 Dec 20221.99%−0.13
30 Nov 20222.12%+0.26
15 Nov 20221.86%−0.98
31 Oct 20222.84%+0.74
31 Aug 20222.10%−1.03
15 Aug 20223.13%−3.76
29 Jul 20226.89%−4.76
13 May 202211.65%+2.84
29 Apr 20228.81%+2.56
15 Mar 20226.25%–

Newest first. Scroll inside the table for earlier dates, back to 15 Mar 2022.

Frequently asked questions

How shorted is Sunshine Biopharma Inc. right now?
2.24% of Sunshine Biopharma Inc.'s (SBFM) shares outstanding were reported short for settlement date 31 Aug 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this SBFM's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is SBFM's days to cover?
1.00 days for settlement date 31 Aug 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.